Maarten H. Geurts
- Molecular Biology top 5%
- Genetics top 5%
- Oncology top 10%
- Biomedical Engineering
- Plant Science
- Topics
- CRISPR and Genetic Engineering (7 papers)SARS-CoV-2 and COVID-19 Research (2 papers)Pluripotent Stem Cells Research (2 papers)
- Partner nations
- NetherlandsSwitzerlandUnited States
In The Last Decade
Maarten H. Geurts
18 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Molecular Biology 1.5k
- Genetics 353
- Oncology 286
- Biomedical Engineering 167
- Plant Science 164
Countries citing papers authored by Maarten H. Geurts
This map shows the geographic impact of Maarten H. Geurts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maarten H. Geurts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maarten H. Geurts more than expected).
Fields of papers citing papers by Maarten H. Geurts
This network shows the impact of papers produced by Maarten H. Geurts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maarten H. Geurts. The network helps show where Maarten H. Geurts may publish in the future.
Co-authorship network of co-authors of Maarten H. Geurts
This figure shows the co-authorship network connecting the top 25 collaborators of Maarten H. Geurts. A scholar is included among the top collaborators of Maarten H. Geurts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maarten H. Geurts. Maarten H. Geurts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 8 | |
| 3 | 9 | |
| 4 | 7 | |
| 5 | 27 | |
| 6 | 62 | |
| 7 | 32 | |
| 8 | Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosisbreakdown → | 125 |
| 9 | 2 | |
| 10 | 56 | |
| 11 | 23 | |
| 12 | 5 | |
| 13 | 36 | |
| 14 | 58 | |
| 15 | 21 | |
| 16 | 102 | |
| 17 | 139 | |
| 18 | Evolved Cas9 variants with broad PAM compatibility and high DNA specificitybreakdown → | 1155 |
About Maarten H. Geurts
Maarten H. Geurts is a scholar working on Aging, Physiology and Biophysics, having authored 18 papers that have together received 1.9k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (7 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Pluripotent Stem Cells Research (2 papers). The work is most often cited by research in Business and International Management (160 citations), Aging (120 citations) and Molecular Biology (1.5k citations). Maarten H. Geurts has collaborated with scholars based in Netherlands, Switzerland and United States. Frequent co-authors include Xue Gao, Zhi Lin, Ning Sun, Liwei Chen, David R. Liu, Shannon M. Miller, Weixin Tang, Johnny H. Hu, Holly A. Rees and Hans Clevers. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.